CORPORATE INFORMATION

ATXA Therapeutics Limited is a private company limited by shares.​

Registered in Ireland No. 561857

​

Our pipeline is protected by a growing worldwide patent estate and we have secured Orphan Designation from the EMA (Europe) and the FDA (USA) for our lead drug NTP42 for its primary target indication PAH.